Mathias Wenes

Company: MPC therapeutics

Job title: CTO

Seminars:

Modulating Metabolism During Manufacturing to Improve Anti-Tumour Efficacy & Persistence of CAR-T Cell Therapies 3:00 pm

Overview of MPC Therapeutics’ approach to target the mitochondrial pyruvate carrier (MPC) to reprogamme CAR-T cell metabolism Discussing preclinical data showing MPC inhibition during manufacturing dramatically improves CAR-T cell survival and efficacy Exploring challenges and opportunities in translating novel manufacturing processes targeting metabolism to the clinicRead more

day: Day Two